---
reference_id: "PMID:25199458"
title: PARP and other prospective targets for poisoning cancer cell metabolism.
authors:
- Michels J
- Obrist F
- Castedo M
- Vitale I
- Kroemer G
journal: Biochem Pharmacol
year: '2014'
doi: 10.1016/j.bcp.2014.08.026
content_type: abstract_only
---

# PARP and other prospective targets for poisoning cancer cell metabolism.
**Authors:** Michels J, Obrist F, Castedo M, Vitale I, Kroemer G
**Journal:** Biochem Pharmacol (2014)
**DOI:** [10.1016/j.bcp.2014.08.026](https://doi.org/10.1016/j.bcp.2014.08.026)

## Content

1. Biochem Pharmacol. 2014 Nov 1;92(1):164-71. doi: 10.1016/j.bcp.2014.08.026.
Epub  2014 Sep 6.

PARP and other prospective targets for poisoning cancer cell metabolism.

Michels J(1), Obrist F(2), Castedo M(3), Vitale I(4), Kroemer G(5).

Author information:
(1)Institut Gustave Roussy, 94805 Villejuif, France; Equipe 11, Centre de 
Recherche des Cordeliers, Paris 75005, France; Metabolomics Platform, Institut 
Gustave Roussy, 94805 Villejuif, France.
(2)Equipe 11, Centre de Recherche des Cordeliers, Paris 75005, France; 
Metabolomics Platform, Institut Gustave Roussy, 94805 Villejuif, France; 
Université de Paris Sud, Paris 11, 94805 Villejuif, France.
(3)Equipe 11, Centre de Recherche des Cordeliers, Paris 75005, France; 
Metabolomics Platform, Institut Gustave Roussy, 94805 Villejuif, France.
(4)Regina Elena National Cancer Institute, 00144 Roma, Italy. Electronic 
address: iliovit@gmail.com.
(5)Institut Gustave Roussy, 94805 Villejuif, France; Equipe 11, Centre de 
Recherche des Cordeliers, Paris 75005, France; Metabolomics Platform, Institut 
Gustave Roussy, 94805 Villejuif, France; Pôle de Biologie, Hôpital Européen 
Georges Pompidou, AP-HP, Paris 75908, France; Université Paris Descartes, 
Faculty of Medicine, Paris 75005, France. Electronic address: kroemer@orange.fr.

Increasing evidence indicates that cancer cells rewire their metabolism during 
tumorigenesis. The high intracellular levels of lactate and reactive oxygen 
species (ROS) generated during enhanced aerobic glycolysis and mitochondrial 
oxidative phosphorylation respectively led to oxidative stress. The 
detoxification of these accumulating metabolites and the equilibrium between 
reduced and oxidized nicotine adenine dinucleotide (NADH and NAD(+)) are two 
prominent mechanisms regulating redox status and hence energy homeostasis in 
tumors. Targeting both processes may thus be selectively cytotoxic for cancer 
cells. In this context, the impact of poly(ADP-ribose) polymerase (PARP) 
inhibitors, a class of anticancer agents employed for the treatment of DNA 
repair deficient tumors, on energy homeostasis and mitochondrial respiration 
regulation has potential clinical implications. Here we provide an overview of 
the metabolic reprogramming occurring in cancer cells and discuss the 
translational perspectives of targeting tumor metabolism and redox balance for 
antineoplastic therapy.

Copyright © 2014 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.bcp.2014.08.026
PMID: 25199458 [Indexed for MEDLINE]